María
Díez Campelo
Profesora Asociada CC. Salud
MARÍA DOLORES
CABALLERO BARRIGÓN
Investigadora en el periodo 1998-2022
Publicaciones en las que colabora con MARÍA DOLORES CABALLERO BARRIGÓN (10)
2014
-
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus
Bone Marrow Transplantation, Vol. 49, Núm. 5, pp. 684-690
-
Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host Disease
Biology of Blood and Marrow Transplantation, Vol. 20, Núm. 10, pp. 1580-1585
2012
-
Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation
Transfusion, Vol. 52, Núm. 5, pp. 1086-1091
2010
-
Liver function tests and absolute lymphocyte count at day +100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant
American Journal of Hematology, Vol. 85, Núm. 4, pp. 290-293
2008
-
Prognostic Factors of Chronic Graft-versus-Host Disease Following Allogeneic Peripheral Blood Stem Cell Transplantation: The National Institutes Health Scale Plus the Type of Onset Can Predict Survival Rates and the Duration of Immunosuppressive Therapy
Biology of Blood and Marrow Transplantation, Vol. 14, Núm. 10, pp. 1163-1171
2006
-
Chronic graft-versus-host disease: Pathogenesis and clinical management
Drugs, Vol. 66, Núm. 8, pp. 1041-1057
-
Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Acute Graft-versus-Host Disease (GVHD)
Biology of Blood and Marrow Transplantation, Vol. 12, Núm. 9, pp. 936-941
2005
-
Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena
American Journal of Hematology, Vol. 78, Núm. 4, pp. 302-305
2003
-
Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation
Blood, Vol. 102, Núm. 3, pp. 1108-1113
2002
-
Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation
Leukemia, Vol. 16, Núm. 8, pp. 1423-1431